SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
<p>Abstract</p> <p>Background</p> <p>Smad interacting protein-1 is a transcription factor that is implicated in transforming growth factor-β/bone morphogenetic protein signaling and a repressor of E-cadherin and human telomerase reverse transcriptase. It is also involve...
Main Authors: | Oztas Emin, Acun Tolga, Yagci Tamer, Yakicier Mustafa C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/223 |
Similar Items
-
Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
by: Mingquan Chen, et al.
Published: (2011-01-01) -
Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.
by: Yinghua He, et al.
Published: (2014-01-01) -
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
by: Gang Xu, et al.
Published: (2020-11-01) -
The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
by: Changsong Zhang, Yang Ling, Chenghui Zhang, Yun Xu, Lu Gao, Rong Li, Jing Zhu, Lieying Fan, Lixin Wei
Published: (2012-01-01) -
Hepatoblastomas exhibit marked downregulation driven by promoter DNA hypermethylation
by: Maria Prates Rivas, et al.
Published: (2020-12-01)